{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:46:22Z","timestamp":1777423582365,"version":"3.51.4"},"reference-count":372,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Background: The recent COVID-19 pandemic produced a significant increase in cases and an emergency state was induced worldwide. The current knowledge about the COVID-19 disease concerning diagnoses, patient tracking, the treatment protocol, and vaccines provides a consistent contribution for the primary prevention of the viral infection and decreasing the severity of the SARS-CoV-2 disease. The aim of the present investigation was to produce a general overview about the current findings for the COVID-19 disease, SARS-CoV-2 interaction mechanisms with the host, therapies and vaccines\u2019 immunization findings. Methods: A literature overview was produced in order to evaluate the state-of-art in SARS-CoV-2 diagnoses, prognoses, therapies, and prevention. Results: Concerning to the interaction mechanisms with the host, the virus binds to target with its Spike proteins on its surface and uses it as an anchor. The Spike protein targets the ACE2 cell receptor and enters into the cells by using a special enzyme (TMPRSS2). Once the virion is quietly accommodated, it releases its RNA. Proteins and RNA are used in the Golgi apparatus to produce more viruses that are released. Concerning the therapies, different protocols have been developed in observance of the disease severity and comorbidity with a consistent reduction in the mortality rate. Currently, different vaccines are currently in phase IV but a remarkable difference in efficiency has been detected concerning the more recent SARS-CoV-2 variants. Conclusions: Among the many questions in this pandemic state, the one that recurs most is knowing why some people become more seriously ill than others who instead contract the infection as if it was a trivial flu. More studies are necessary to investigate the efficiency of the treatment protocols and vaccines for the more recent detected SARS-CoV-2 variant.<\/jats:p>","DOI":"10.3390\/ijms23158485","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T02:06:42Z","timestamp":1659319602000},"page":"8485","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6366-1039","authenticated-orcid":false,"given":"Alessio Danilo","family":"Inchingolo","sequence":"first","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9745-7506","authenticated-orcid":false,"given":"Giuseppina","family":"Malcangi","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7839-4623","authenticated-orcid":false,"given":"Sabino","family":"Ceci","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7395-3126","authenticated-orcid":false,"given":"Assunta","family":"Patano","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9760-9394","authenticated-orcid":false,"given":"Alberto","family":"Corriero","sequence":"additional","affiliation":[{"name":"Unit of Anesthesia and Resuscitation, Department of Emergencies and Organ Transplantations, Aldo Moro University, 70121 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4072-2871","authenticated-orcid":false,"given":"Luigi","family":"Vimercati","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1307-8582","authenticated-orcid":false,"given":"Daniela","family":"Azzollini","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-2350","authenticated-orcid":false,"given":"Grazia","family":"Marinelli","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1327-5762","authenticated-orcid":false,"given":"Giovanni","family":"Coloccia","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0765-7710","authenticated-orcid":false,"given":"Fabio","family":"Piras","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4027-4105","authenticated-orcid":false,"given":"Giuseppe","family":"Barile","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4145-3455","authenticated-orcid":false,"given":"Vito","family":"Settanni","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7103-4086","authenticated-orcid":false,"given":"Antonio","family":"Mancini","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1974-3475","authenticated-orcid":false,"given":"Nicole","family":"De Leonardis","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Garofoli","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0292-1965","authenticated-orcid":false,"given":"Giulia","family":"Palmieri","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro Gargiulo","family":"Isacco","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-6594","authenticated-orcid":false,"given":"Biagio","family":"Rapone","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaldo","family":"Scardapane","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Curatoli","sequence":"additional","affiliation":[{"name":"Department Neurosciences & Sensory Organs & Musculoskeletal System, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6214-2336","authenticated-orcid":false,"given":"Nicola","family":"Quaranta","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"},{"name":"Department Neurosciences & Sensory Organs & Musculoskeletal System, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Ribezzi","sequence":"additional","affiliation":[{"name":"Unit of Anesthesia and Resuscitation, Department of Emergencies and Organ Transplantations, Aldo Moro University, 70121 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Massaro","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-9949","authenticated-orcid":false,"given":"Ioana Roxana","family":"Bordea","sequence":"additional","affiliation":[{"name":"Department of Oral Rehabilitation, Faculty of Dentistry, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-5143","authenticated-orcid":false,"given":"Gianluca Martino","family":"Tartaglia","sequence":"additional","affiliation":[{"name":"UOC Maxillo-Facial Surgery and Dentistry, Department of Biomedical, Surgical and Dental Sciences, School of Dentistry, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, University of Milan, 20100 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Scarano","sequence":"additional","affiliation":[{"name":"Department of Innovative Technologies in Medicine and Dentistry, University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-9231","authenticated-orcid":false,"given":"Felice","family":"Lorusso","sequence":"additional","affiliation":[{"name":"Department of Innovative Technologies in Medicine and Dentistry, University of Chieti-Pescara, 66100 Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Macchia","sequence":"additional","affiliation":[{"name":"Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari Aldo Moro, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Maria Vittoria","family":"Larocca","sequence":"additional","affiliation":[{"name":"Hygiene Complex Operating Unit, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Place Giulio Cesare 11 BARI CAP, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey Khachatur","family":"Aityan","sequence":"additional","affiliation":[{"name":"Director Multidisciplinary Research Center, Lincoln University, Oakland, CA 94612, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4194-0210","authenticated-orcid":false,"given":"Silvio","family":"Tafuri","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science and Human Oncology, University of Bari, 70121 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Stefanizzi","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, University Hospital of Bari, 70100 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Migliore","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, University Hospital of Bari, 70100 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Brienza","sequence":"additional","affiliation":[{"name":"Unit of Anesthesia and Resuscitation, Department of Emergencies and Organ Transplantations, Aldo Moro University, 70121 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5947-8987","authenticated-orcid":false,"given":"Gianna","family":"Dipalma","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Favia","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3797-5883","authenticated-orcid":false,"given":"Francesco","family":"Inchingolo","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine, Section of Dental Medicine, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"112934","DOI":"10.1016\/j.psychres.2020.112934","article-title":"The Psychological Impact of the COVID-19 Epidemic on College Students in China","volume":"287","author":"Cao","year":"2020","journal-title":"Psychiatry Res."},{"key":"ref_2","unstructured":"CDC (2022, July 11). CDC 2020-2021 Flu Vaccine Campaign Kickoff, Available online: https:\/\/www.cdc.gov\/flu\/spotlights\/2020-2021\/2020-21-campaign-kickoff.htm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/irv.12735","article-title":"Uncertainties about the Transmission Routes of 2019 Novel Coronavirus","volume":"14","author":"Han","year":"2020","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jama.2020.12458","article-title":"Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence","volume":"324","author":"Klompas","year":"2020","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11606-020-05762-w","article-title":"Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)","volume":"35","author":"Jiang","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Spagnolo, L., Vimercati, L., Caputi, A., Benevento, M., De Maria, L., Ferorelli, D., and Solarino, B. (2021). Role and Tasks of the Occupational Physician during the COVID-19 Pandemic. Medicina, 57.","DOI":"10.3390\/medicina57050479"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1038\/s41598-021-85215-4","article-title":"Determinants of SARS-CoV-2 Infection in Italian Healthcare Workers: A Multicenter Study","volume":"11","author":"Boffetta","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ijid.2020.10.098","article-title":"COVID-19 Hospital Outbreaks: Protecting Healthcare Workers to Protect Frail Patients. An Italian Observational Cohort Study","volume":"102","author":"Vimercati","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1377\/hlthaff.2015.1088","article-title":"The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness","volume":"35","author":"Luyten","year":"2016","journal-title":"Health Aff."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Scarano, A., Inchingolo, F., and Lorusso, F. (2020). Facial Skin Temperature and Discomfort When Wearing Protective Face Masks: Thermal Infrared Imaging Evaluation and Hands Moving the Mask. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17134624"},{"key":"ref_11","first-page":"e2020126","article-title":"What We Have Learned for the Future about COVID-19 and Healthcare Management of It?","volume":"91","author":"Charitos","year":"2020","journal-title":"Acta Biomed."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tripleo.2010.05.056","article-title":"Selecting a Relevant in Vitro Cell Model for Testing and Comparing the Effects of a Choukroun\u2019s Platelet-Rich Fibrin (PRF) Membrane and a Platelet-Rich Plasma (PRP) Gel: Tricks and Traps","volume":"110","author":"Inchingolo","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8896812","DOI":"10.1155\/2020\/8896812","article-title":"Environmental Disinfection of a Dental Clinic during the COVID-19 Pandemic: A Narrative Insight","volume":"2020","author":"Scarano","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Scarano, A., Inchingolo, F., Rapone, B., Festa, F., Tari, S.R., and Lorusso, F. (2021). Protective Face Masks: Effect on the Oxygenation and Heart Rate Status of Oral Surgeons during Surgery. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18052363"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Inchingolo, A.D., Inchingolo, A.M., Bordea, I.R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G.M., and Isacco, C.G. (2021). SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms, 9.","DOI":"10.3390\/microorganisms9030525"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.arcmed.2020.05.012","article-title":"Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2","volume":"51","author":"Satarker","year":"2020","journal-title":"Arch. Med. Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yadav, R., Chaudhary, J.K., Jain, N., Chaudhary, P.K., Khanra, S., Dhamija, P., Sharma, A., Kumar, A., and Handu, S. (2021). Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19. Cells, 10.","DOI":"10.3390\/cells10040821"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Balzanelli, M.G., Distratis, P., Lazzaro, R., D\u2019Ettorre, E., Nico, A., Inchingolo, F., Dipalma, G., Tomassone, D., Serlenga, E.M., and Dalagni, G. (2022). New Translational Trends in Personalized Medicine: Autologous Peripheral Blood Stem Cells and Plasma for COVID-19 Patient. J. Pers. Med., 12.","DOI":"10.3390\/jpm12010085"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and Functional Properties of SARS-CoV-2 Spike Protein: Potential Antivirus Drug Development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharm. Sin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1038\/s41467-020-18319-6","article-title":"Molecular Interaction and Inhibition of SARS-CoV-2 Binding to the ACE2 Receptor","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41423-020-00573-9","article-title":"Low Serum Neutralizing Anti-SARS-CoV-2 S Antibody Levels in Mildly Affected COVID-19 Convalescent Patients Revealed by Two Different Detection Methods","volume":"18","author":"Stein","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Arashkia, A., Jalilvand, S., Mohajel, N., Afchangi, A., Azadmanesh, K., Salehi-Vaziri, M., Fazlalipour, M., Pouriayevali, M.H., Jalali, T., and Mousavi Nasab, S.D. (2021). Severe Acute Respiratory Syndrome-coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects. Rev. Med. Virol., 31.","DOI":"10.1002\/rmv.2183"},{"key":"ref_23","unstructured":"(2022, January 07). Tracking SARS-CoV-2 Variants. Available online: https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/14760584.2022.2044800","article-title":"Global Impact of Delta plus Variant and Vaccination","volume":"21","author":"Chavda","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"ref_25","unstructured":"(2022, January 07). Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. Available online: https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern."},{"key":"ref_26","first-page":"eabn4947","article-title":"Increased Risk of SARS-CoV-2 Reinfection Associated with Emergence of the Omicron Variant in South Africa","volume":"376","author":"Pulliam","year":"2021","journal-title":"MedRxiv"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/d41586-021-03614-z","article-title":"How Bad Is Omicron? What Scientists Know so Far","volume":"600","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/cid\/ciaa461","article-title":"Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019","volume":"71","author":"Xiang","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","unstructured":"WHO (2022, January 07). Prevention SARS-CoV-2 Variant Classifications and Definitions. Available online: https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants."},{"key":"ref_30","unstructured":"(2022, July 12). Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel Set of Spike Mutations\u2014SARS-CoV-2 Coronavirus\/NCoV-2019 Genomic Epidemiology. Available online: https:\/\/virological.org\/t\/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations\/563."},{"key":"ref_31","unstructured":"Horby, P., and Barclay, W. (2021). NERVTAG Paper Brief Update on SARS-CoV-2 Variants [New Text in Red]. 5, Scientific Advisory Group for Emergencies."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J.C., Johnson, R., Geidelberg, L., Hinsley, W.R., Laydon, D.J., and Dabrera, G. (2021). Assessing Transmissibility of SARS-CoV-2 Lineage B.1.1.7 in England. Nature, 593, 266\u2013269.","DOI":"10.1038\/s41586-021-03470-x"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJMsr2105280","article-title":"SARS-CoV-2 Variants and Vaccines","volume":"385","author":"Krause","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jama.2020.27124","article-title":"Genetic Variants of SARS-CoV-2\u2014What Do They Mean?","volume":"325","author":"Lauring","year":"2021","journal-title":"JAMA"},{"key":"ref_35","first-page":"3357","article-title":"The Impact of COVID-19 on the Scientific Production Spread: A Five-Month Bibliometric Report of the Worldwide Research Community","volume":"36","author":"Lorusso","year":"2020","journal-title":"Acta Med. Mediterr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/d41586-020-02544-6","article-title":"The Coronavirus Is Mutating\u2014Does It Matter?","volume":"585","author":"Callaway","year":"2020","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1002\/jmv.27103","article-title":"Genome-wide Analysis of SARS-CoV-2 Strains Circulating in Vietnam: Understanding the Nature of the Epidemic and Role of the D614G Mutation","volume":"93","author":"Dao","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Nguyen, T.T., Pham, T.N., Van, T.D., Nguyen, T.T., Nguyen, D.T.N., Le, H.N.M., Eden, J.-S., Rockett, R.J., Nguyen, T.T.H., and Vu, B.T.N. (2020). Genetic Diversity of SARS-CoV-2 and Clinical, Epidemiological Characteristics of COVID-19 Patients in Hanoi, Vietnam. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0242537"},{"key":"ref_39","unstructured":"Aleem, A., Akbar Samad, A.B., and Slenker, A.K. (2021). Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). StatPearls, StatPearls Publishing."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kim, Y.J., Jang, U.S., Soh, S.M., Lee, J.-Y., and Lee, H.-R. (2021). The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus. Viruses, 13.","DOI":"10.3390\/v13040633"},{"key":"ref_41","first-page":"739","article-title":"Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant","volume":"183","author":"Yurkovetskiy","year":"2020","journal-title":"Microbiology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking Changes in SARS-CoV-2 Spike: Evidence That D614G Increases Infectivity of the COVID-19 Virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"ref_43","unstructured":"Yurkovetskiy, L., Pascal, K.E., Tomkins-Tinch, C., Nyalile, T., Wang, Y., Baum, A., Diehl, W.E., Dauphin, A., Carbone, C., and Veinotte, K. (2020). SARS-CoV-2 Spike Protein Variant D614G Increases Infectivity and Retains Sensitivity to Antibodies That Target the Receptor Binding Domain. BioRxiv."},{"key":"ref_44","first-page":"1","article-title":"SARS-CoV-2 Variants of Concern and Variants under Investigation in England","volume":"11","author":"England","year":"2021","journal-title":"Public Health Engl."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e65113","DOI":"10.7554\/eLife.65113","article-title":"Saliva TwoStep for Rapid Detection of Asymptomatic SARS-CoV-2 Carriers","volume":"10","author":"Yang","year":"2021","journal-title":"eLife"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"114143","DOI":"10.1016\/j.jviromet.2021.114143","article-title":"A Novel Single Nucleotide Polymorphism Assay for the Detection of N501Y SARS-CoV-2 Variants","volume":"294","year":"2021","journal-title":"J. Virol. Methods"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"672562","DOI":"10.3389\/fcimb.2021.672562","article-title":"RT-QPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants with Clinical Impact","volume":"11","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"111653","DOI":"10.1016\/j.envres.2021.111653","article-title":"Direct RT-QPCR Assay for SARS-CoV-2 Variants of Concern (Alpha, B.1.1.7 and Beta, B.1.351) Detection and Quantification in Wastewater","volume":"201","author":"Yaniv","year":"2021","journal-title":"Environ. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Vogels, C.B.F., Breban, M.I., Ott, I.M., Alpert, T., Petrone, M.E., Watkins, A.E., Kalinich, C.C., Earnest, R., Rothman, J.E., and Goes de Jesus, J. (2021). Multiplex QPCR Discriminates Variants of Concern to Enhance Global Surveillance of SARS-CoV-2. PLoS Biol., 19.","DOI":"10.1371\/journal.pbio.3001236"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"117104","DOI":"10.1016\/j.watres.2021.117104","article-title":"Rapid Screening for SARS-CoV-2 Variants of Concern in Clinical and Environmental Samples Using Nested RT-PCR Assays Targeting Key Mutations of the Spike Protein","volume":"197","author":"Mancini","year":"2021","journal-title":"Water Res."},{"key":"ref_51","unstructured":"Vircell (2022, July 12). Available online: https:\/\/en.vircell.com\/."},{"key":"ref_52","unstructured":"(2022, July 12). New VIASURE SARS-CoV-2 Variant I & Variant II RT-PCR Kits\u2014CERTEST Biotec IVD Diagnostic Products. Available online: https:\/\/www.certest.es\/news\/new-viasure-sars-cov-2-variant-i-variant-ii-rt-pcr-kits\/."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8483658","DOI":"10.1155\/2019\/8483658","article-title":"Observational Study on the Preparation of the Implant Site with Piezosurgery vs. Drill: Comparison between the Two Methods in Terms of Postoperative Pain, Surgical Times, and Operational Advantages","volume":"2019","author":"Maglione","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Inchingolo, A.D., Dipalma, G., Inchingolo, A.M., Malcangi, G., Santacroce, L., D\u2019oria, M.T., Isacco, C.G., Bordea, I.R., Candrea, S., and Scarano, A. (2021). The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants. Antioxidants, 10.","DOI":"10.3390\/antiox10060881"},{"key":"ref_55","first-page":"7173","article-title":"Rapid and Sensitive Diagnostic Procedure for Multiple Detection of Pandemic Coronaviridae Family Members SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV: A Translational Research and Cooperation between the Phan Chau Trinh University in Vietnam and University of Bari \u201cAldo Moro\u201d in Italy","volume":"24","author":"Pham","year":"2020","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_56","unstructured":"(2021, August 19). GISAID\u2014HCov19 Variants. Available online: https:\/\/www.gisaid.org\/hcov19-variants\/."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kimura, I., Kosugi, Y., Wu, J., Yamasoba, D., Butlertanaka, E.P., Tanaka, Y.L., Liu, Y., Shirakawa, K., Kazuma, Y., and Nomura, R. (2021). SARS-CoV-2 Lambda Variant Exhibits Higher Infectivity and Immune Resistance. bioRxiv.","DOI":"10.1101\/2021.07.28.454085"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Acevedo, M.L., Alonso-Palomares, L., Bustamante, A., Gaggero, A., Paredes, F., Cort\u00e9s, C.P., Valiente-Echeverr\u00eda, F., and Soto-Rifo, R. (2021). Infectivity and Immune Escape of the New SARS-CoV-2 Variant of Interest Lambda. medRxiv.","DOI":"10.1101\/2021.06.28.21259673"},{"key":"ref_59","unstructured":"KFF (2021, August 19). COVID-19 Vaccine Breakthrough Cases: Data from the States. Available online: https:\/\/www.kff.org\/policy-watch\/covid-19-vaccine-breakthrough-cases-data-from-the-states\/."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00028-20","DOI":"10.1128\/CMR.00028-20","article-title":"Coronavirus Disease 2019\u2013COVID-19","volume":"33","author":"Dhama","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.15585\/mmwr.mm7030e2","article-title":"CDC COVID-19 Response Team Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage","volume":"70","author":"Christie","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/jama.2021.15125","article-title":"Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and MRNA-1273","volume":"326","author":"Steensels","year":"2021","journal-title":"JAMA"},{"key":"ref_63","unstructured":"Latin America DW (2022, July 12). Coronavirus Lambda Variant Spreads across Latin America. Available online: https:\/\/www.dw.com\/en\/coronavirus-lambda-variant-spreads-across-latin-america\/a-58035249."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2021.07.002","article-title":"COVID-19 in Children: Where Do We Stand?","volume":"53","author":"Nikolopoulou","year":"2021","journal-title":"Arch. Med. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A Human Homolog of Angiotensin-Converting Enzyme","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Balzanelli, M.G., Distratis, P., Catucci, O., Cefalo, A., Lazzaro, R., Inchingolo, F., Tomassone, D., Aityan, S.K., Ballini, A., and Nguyen, K.C. (2021). Mesenchymal Stem Cells: The Secret Children\u2019s Weapons against the SARS-CoV-2 Lethal Infection. Appl. Sci., 11.","DOI":"10.3390\/app11041696"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08977190802636713","article-title":"Slow Release of Growth Factors and Thrombospondin-1 in Choukroun\u2019s Platelet-Rich Fibrin (PRF): A Gold Standard to Achieve for All Surgical Platelet Concentrates Technologies","volume":"27","author":"Doglioli","year":"2009","journal-title":"Growth Factors"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jama.293.12.1450-c","article-title":"ABO Blood Group and Susceptibility to Severe Acute Respiratory Syndrome","volume":"293","author":"Cheng","year":"2005","journal-title":"JAMA"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Breiman, A., Ruv\u00ebn-Clouet, N., and Le Pendu, J. (2020). Harnessing the Natural Anti-Glycan Immune Response to Limit the Transmission of Enveloped Viruses Such as SARS-CoV-2. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008556"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/bloodadvances.2020003259","article-title":"The SARS-CoV-2 Receptor-Binding Domain Preferentially Recognizes Blood Group A","volume":"5","author":"Wu","year":"2021","journal-title":"Blood Adv."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/CMR.00109-14","article-title":"Blood Groups in Infection and Host Susceptibility","volume":"28","author":"Cooling","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2010-01-261859","article-title":"The Relationship between Blood Groups and Disease","volume":"115","author":"Anstee","year":"2010","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/jclinpath-2020-206658","article-title":"Gene of the Month: The 2019-NCoV\/SARS-CoV-2 Novel Coronavirus Spike Protein","volume":"73","author":"Pillay","year":"2020","journal-title":"J. Clin. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/22221751.2020.1723441","article-title":"An Emerging Coronavirus Causing Pneumonia Outbreak in Wuhan, China: Calling for Developing Therapeutic and Prophylactic Strategies","volume":"9","author":"Jiang","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Inchingolo, A.D., Inchingolo, A.M., Bordea, I.R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G.M., and Isacco, C.G. (2021). SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs. Microorganisms, 9.","DOI":"10.3390\/microorganisms9040793"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion Mechanism of 2019-NCoV and Fusion Inhibitors Targeting HR1 Domain in Spike Protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2217\/fvl-2018-0008","article-title":"Post-Translational Modifications of Coronavirus Proteins: Roles and Function","volume":"13","author":"Fung","year":"2018","journal-title":"Future Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1021\/acs.jproteome.0c00129","article-title":"Protein Structure and Sequence Reanalysis of 2019-NCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1","volume":"19","author":"Zhang","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zhang, T., Wu, Q., and Zhang, Z. (2020). Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. Curr. Biol., 30.","DOI":"10.1016\/j.cub.2020.03.063"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/prot.26042","article-title":"Human SARS-CoV-2 Spike Protein Mutations","volume":"89","author":"Guruprasad","year":"2021","journal-title":"Proteins: Struct. Funct. Bioinform."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Wang, Q., Zhang, Y., Wu, L., Niu, S., Song, C., Zhang, Z., Lu, G., Qiao, C., Hu, Y., and Yuen, K.-Y. (2020). Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell, 181.","DOI":"10.1016\/j.cell.2020.03.045"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/096876899294706","article-title":"Structural Basis for Membrane Fusion by Enveloped Viruses","volume":"16","author":"Weissenhorn","year":"1999","journal-title":"Mol. Membr. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Balzanelli, M.G., Distratis, P., Lazzaro, R., Cefalo, A., Catucci, O., Aityan, S.K., Dipalma, G., Vimercati, L., Inchingolo, A.D., and Maggiore, M.E. (2021). The Vitamin D, IL-6 and the EGFR Markers a Possible Way to Elucidate the Lung\u2013Heart\u2013Kidney Cross-Talk in COVID-19 Disease: A Foregone Conclusion. Microorganisms, 9.","DOI":"10.3390\/microorganisms9091903"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM Structure of the 2019-NCoV Spike in the Prefusion Conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The Trinity of COVID-19: Immunity, Inflammation and Intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host Cell Proteases: Critical Determinants of Coronavirus Tropism and Pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1146\/annurev.biochem.70.1.777","article-title":"Mechanisms of Viral Membrane Fusion and Its Inhibition","volume":"70","author":"Eckert","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The Molecular Biology of Coronaviruses","volume":"Volume 66","author":"Masters","year":"2006","journal-title":"Advances in Virus Research"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/jmv.25832","article-title":"Structural Variations in Human ACE2 May Influence Its Binding with SARS-CoV-2 Spike Protein","volume":"92","author":"Hussain","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-Converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","article-title":"Trilogy of ACE2: A Peptidase in the Renin\u2013Angiotensin System, a SARS Receptor, and a Partner for Amino Acid Transporters","volume":"128","author":"Kuba","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The Pivotal Link between ACE2 Deficiency and SARS-CoV-2 Infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Tetz, G., and Tetz, V. (2020). SARS-CoV-2 Prion-Like Domains in Spike Proteins Enable Higher Affinity to ACE2. Microorganisms, 10.","DOI":"10.20944\/preprints202003.0422.v1"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"105131","DOI":"10.1016\/j.nbd.2020.105131","article-title":"The SARS-CoV-2 Spike Protein Alters Barrier Function in 2D Static and 3D Microfluidic in-Vitro Models of the Human Blood\u2013Brain Barrier","volume":"146","author":"Buzhdygan","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The Blood\u2013Brain Barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e01476-14","DOI":"10.1128\/mBio.01476-14","article-title":"Viral Pathogen-Associated Molecular Patterns Regulate Blood-Brain Barrier Integrity via Competing Innate Cytokine Signals","volume":"5","author":"Daniels","year":"2014","journal-title":"mBio"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Cao, Y., Su, B., Guo, X., Sun, W., Deng, Y., Bao, L., Zhu, Q., Zhang, X., Zheng, Y., and Geng, C. (2020). Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients\u2019 B Cells. Cell, 182.","DOI":"10.1016\/j.cell.2020.05.025"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human Neutralizing Antibodies Elicited by SARS-CoV-2 Infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"ref_107","first-page":"450","article-title":"Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike","volume":"584","author":"Liu","year":"2020","journal-title":"Microbiology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent Neutralizing Antibodies from COVID-19 Patients Define Multiple Targets of Vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Qin, X., Shen, J., Dai, E., Li, H., Tang, G., Zhang, L., Hou, X., Lu, M., Wu, X., and Duan, S. (2021). The Seroprevalence and Kinetics of IgM and IgG in the Progression of COVID-19. BMC Immunol., 22.","DOI":"10.1186\/s12865-021-00404-0"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Attolico, I., Tarantini, F., Carluccio, P., Schifone, C.P., Delia, M., Gagliardi, V.P., Perrone, T., Gaudio, F., Longo, C., and Giordano, A. (2021). Serological Response Following BNT162b2 Anti-SARS-CoV-2 MRNA Vaccination in Haematopoietic Stem Cell Transplantation Patients. Br. J. Haematol.","DOI":"10.1111\/bjh.17873"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/cid\/ciaa489","article-title":"Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Qu","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"110793","DOI":"10.1016\/j.envres.2021.110793","article-title":"Large-Scale IgM and IgG SARS-CoV-2 Serological Screening among Healthcare Workers with a Low Infection Prevalence Based on Nasopharyngeal Swab Tests in an Italian University Hospital: Perspectives for Public Health","volume":"195","author":"Vimercati","year":"2021","journal-title":"Environ. Res"},{"key":"ref_113","first-page":"1","article-title":"Combined Anti-SARS-CoV-2 IgA, IgG, and IgM Detection as a Better Strategy to Prevent Second Infection Spreading Waves","volume":"51","author":"Nuccetelli","year":"2020","journal-title":"Immunol. Investig."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.vaccine.2008.11.093","article-title":"Efficacy of Live Attenuated Influenza Vaccine in Children: A Meta-Analysis of Nine Randomized Clinical Trials","volume":"27","author":"Rhorer","year":"2009","journal-title":"Vaccine"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Xu, M., Wang, D., Wang, H., Zhang, X., Liang, T., Dai, J., Li, M., Zhang, J., Zhang, K., and Xu, D. (2020). COVID-19 Diagnostic Testing: Technology Perspective. Clin. Transl. Med., 10.","DOI":"10.1002\/ctm2.158"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Kowitdamrong, E., Puthanakit, T., Jantarabenjakul, W., Prompetchara, E., Suchartlikitwong, P., Putcharoen, O., and Hirankarn, N. (2020). Antibody Responses to SARS-CoV-2 in Patients with Differing Severities of Coronavirus Disease 2019. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0240502"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jmii.2020.05.001","article-title":"A Systematic Review of Asymptomatic Infections with COVID-19","volume":"54","author":"Gao","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"101735","DOI":"10.1016\/j.isci.2020.101735","article-title":"Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk","volume":"23","author":"Fox","year":"2020","journal-title":"iScience"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/08820139.2020.1795191","article-title":"Immune Responses to the Novel Coronavirus-2: Friend or Foe?","volume":"50","author":"Mahmoodpoor","year":"2021","journal-title":"Immunol. Investig."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jceh.2020.03.001","article-title":"Gastrointestinal and Liver Manifestations of COVID-19","volume":"10","author":"Agarwal","year":"2020","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Ballini, A., Dipalma, G., Isacco, C.G., Boccellino, M., Di Domenico, M., Santacroce, L., Nguy\u1ec5n, K.C.D., Scacco, S., Calvani, M., and Boddi, A. (2020). Oral Microbiota and Immune System Crosstalk: A Translational Research. Biology, 9.","DOI":"10.3390\/biology9060131"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)","volume":"71","author":"Guo","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Tetz, G., and Tetz, V. (2022). Prion-Like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2. Microorganisms, 10.","DOI":"10.3390\/microorganisms10020280"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3889\/oamjms.2018.406","article-title":"Probiotics Improve Urogenital Health in Women","volume":"6","author":"Ballini","year":"2018","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2020.04.026","article-title":"IgA-Ab Response to Spike Glycoprotein of SARS-CoV-2 in Patients with COVID-19: A Longitudinal Study","volume":"507","author":"Padoan","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1515\/cclm-2020-0443","article-title":"Analytical Performances of a Chemiluminescence Immunoassay for SARS-CoV-2 IgM\/IgG and Antibody Kinetics","volume":"58","author":"Padoan","year":"2020","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Chen, L., Zhao, J., Peng, J., Li, X., Deng, X., Geng, Z., Shen, Z., Guo, F., Zhang, Q., and Jin, Y. (2020). Detection of SARS-CoV-2 in Saliva and Characterization of Oral Symptoms in COVID-19 Patients. Cell Prolif., 53.","DOI":"10.1111\/cpr.12923"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Rapone, B., Ferrara, E., Santacroce, L., Topi, S., Gnoni, A., Dipalma, G., Mancini, A., Di Domenico, M., Tartaglia, G.M., and Scarano, A. (2022). The Gaseous Ozone Therapy as a Promising Antiseptic Adjuvant of Periodontal Treatment: A Randomized Controlled Clinical Trial. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19020985"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Phan, D.Q., Nguyen, L.D.N., Pham, S.T., Nguyen, T., Pham, P.T.T., Nguyen, S.T.H., Pham, D.T., Pham, H.T., Tran, D.K., and Le, S.H. (2022). The Distribution of Dengue Virus Serotype in Quang Nam Province (Vietnam) during the Outbreak in 2018. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19031285"},{"key":"ref_130","unstructured":"(2022, July 12). Indonesia First to Greenlight Novavax COVID-19 Vaccine | AP News. Available online: https:\/\/apnews.com\/article\/coronavirus-pandemic-technology-science-business-health-7e75808d4675e0e7597f52aeed1b8d5a."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"16561","DOI":"10.1038\/s41598-020-73491-5","article-title":"SARS-CoV-2 S1 and N-Based Serological Assays Reveal Rapid Seroconversion and Induction of Specific Antibody Response in COVID-19 Patients","volume":"10","author":"Algaissi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e00512-20","DOI":"10.1128\/JCM.00512-20","article-title":"Laboratory Diagnosis of COVID-19: Current Issues and Challenges","volume":"58","author":"Tang","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/jmv.25727","article-title":"Development and Clinical Application of a Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Adeyinka, A., Bailey, K., Pierre, L., and Kondamudi, N. (2021). COVID 19 Infection: Pediatric Perspectives. J. Am. Coll. Emerg. Physicians Open, 2.","DOI":"10.1002\/emp2.12375"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.15585\/mmwr.mm6905e1","article-title":"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak\u2014United States, December 31, 2019\u2013February 4, 2020","volume":"69","author":"Patel","year":"2020","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Bellocchio, L., Inchingolo, A.D., Inchingolo, A.M., Lorusso, F., Malcangi, G., Santacroce, L., Scarano, A., Bordea, I.R., Hazballa, D., and D\u2019Oria, M.T. (2021). Cannabinoids Drugs and Oral Health-From Recreational Side-Effects to Medicinal Purposes: A Systematic Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158329"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"112830","DOI":"10.1016\/j.bios.2020.112830","article-title":"Diagnosis of COVID-19 for Controlling the Pandemic: A Review of the State-of-the-Art","volume":"174","author":"Taleghani","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/imcb.12397","article-title":"Antibody Detection Assays for COVID-19 Diagnosis: An Early Overview","volume":"99","author":"Ejazi","year":"2021","journal-title":"Immunol. Cell Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e03149-20","DOI":"10.1128\/JCM.03149-20","article-title":"Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation","volume":"59","author":"Higgins","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Rokni, M., Ghasemi, V., and Tavakoli, Z. (2020). Immune Responses and Pathogenesis of SARS-CoV-2 during an Outbreak in Iran: Comparison with SARS and MERS. Rev. Med. Virol., 30.","DOI":"10.1002\/rmv.2107"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/cbin.11516","article-title":"Serological Tests for COVID-19: Potential Opportunities","volume":"45","author":"Tantuoyir","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Werner, M., Pervan, P., Gl\u00fcck, V., Zeman, F., Koller, M., Burkhardt, R., Gl\u00fcck, T., Wenzel, J.J., Schmidt, B., and Gessner, A. (2021). Evaluation of a Broad Panel of SARS-CoV-2 Serological Tests for Diagnostic Use. J. Clin. Med., 10.","DOI":"10.3390\/jcm10081580"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1080\/22221751.2020.1762515","article-title":"Kinetics of SARS-CoV-2 Specific IgM and IgG Responses in COVID-19 Patients","volume":"9","author":"Sun","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Kyosei, Y., Namba, M., Makioka, D., Kokubun, A., Watabe, S., Yoshimura, T., Sasaki, T., Shioda, T., and Ito, E. (2021). Ultrasensitive Detection of SARS-CoV-2 Spike Proteins Using the Thio-NAD Cycling Reaction: A Preliminary Study before Clinical Trials. Microorganisms, 9.","DOI":"10.3390\/microorganisms9112214"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3201\/eid2607.200841","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2- Specific Antibody Responses in Coronavirus Disease Patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_146","first-page":"e02492-20","article-title":"Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera","volume":"12","author":"Oguntuyo","year":"2020","journal-title":"Infect. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus Infections and Immune Responses","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B Cell Regulation in Cancer and Anti-Tumor Immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Atri, C., Guerfali, F., and Laouini, D. (2018). Role of Human Macrophage Polarization in Inflammation during Infectious Diseases. IJMS, 19.","DOI":"10.3390\/ijms19061801"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40001-021-00516-8","article-title":"Genetic Susceptibility of COVID-19: A Systematic Review of Current Evidence","volume":"26","author":"SeyedAlinaghi","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Sang, E.R., Tian, Y., Miller, L.C., and Sang, Y. (2021). Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates. Genes, 12.","DOI":"10.1101\/2020.09.09.273268"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","article-title":"Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines","volume":"50","author":"Murakami","year":"2019","journal-title":"Immunity"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: Designing Specific Therapeutics for a Complex Cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Morelli, C., Francavilla, M., Stabile Ianora, A.A., Cozzolino, M., Gualano, A., Stellacci, G., Sacco, A., Lorusso, F., Pedote, P., and De Ceglie, M. (2021). The Multifaceted COVID-19: CT Aspects of Its Atypical Pulmonary and Abdominal Manifestations and Complications in Adults and Children. A Pictorial Review. Microorganisms, 9.","DOI":"10.3390\/microorganisms9102037"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Bhimraj, A., Morgan, R.L., Shumaker, A.H., Lavergne, V., Baden, L., Cheng, V.C.-C., Edwards, K.M., Gandhi, R., Muller, W.J., and O\u2019Horo, J.C. (2020). Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With Coronavirus Disease 2019 (COVID-19). Clin. Infect. Dis., ciaa478.","DOI":"10.1093\/cid\/ciaa478"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3889\/oamjms.2020.5480","article-title":"COVID-19 and COVID-like Patients: A Brief Analysis and Findings of Two Deceased Cases","volume":"8","author":"Balzanelli","year":"2020","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"23149","DOI":"10.26717\/BJSTR.2020.30.004908","article-title":"Could Immunity Boosting Therapy Help COVID-19 Patient?","volume":"30","author":"Nguyen","year":"2020","journal-title":"BJSTR"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"eabl4348","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-Linked Recessive TLR7 Deficiency in ~1% of Men under 60 Years Old with Life-Threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Scarano, A., Petrini, M., Mastrangelo, F., Noumbissi, S., and Lorusso, F. (2020). The Effects of Liquid Disinfection and Heat Sterilization Processes on Implant Drill Roughness: Energy Dispersion X-Ray Microanalysis and Infrared Thermography. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041019"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Inchingolo, A.D., Malcangi, G., Inchingolo, A.M., Piras, F., Settanni, V., Garofoli, G., Palmieri, G., Ceci, S., Patano, A., and De Leonardis, N. (2022). Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the Literature. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23074027"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn Errors of Type I IFN Immunity in Patients with Life-Threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"ref_163","first-page":"22921","article-title":"Clinical Features in Predicting COVID-19","volume":"29","author":"Balzanelli","year":"2020","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"ref_164","unstructured":"Balzanelli, M.G., Distratis, P., Lazzaro, R., Cefalo, A., Dangela, G., Catucci, O., Palazzo, D., Amatulli, F., Tomassone, D., and Pham, V. (2020). Would the End Of COVID-19 Infection as a Chronic Disease?. J. Stem Cells Res. Dev. Ther."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/22123873MTEzlNzIr1","article-title":"An Alternative \u201cTrojan Horse\u201d Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology","volume":"22","author":"Balzanelli","year":"2021","journal-title":"EMIDDT"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Bevilacqua, V., Altini, N., Prencipe, B., Brunetti, A., Villani, L., Sacco, A., Morelli, C., Ciaccia, M., and Scardapane, A. (2021). Lung Segmentation and Characterization in COVID-19 Patients for Assessing Pulmonary Thromboembolism: An Approach Based on Deep Learning and Radiomics. Electronics, 10.","DOI":"10.3390\/electronics10202475"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijid.2020.06.066","article-title":"Occurrence of Acute Pulmonary Embolism in COVID-19-A Case Series","volume":"98","author":"Bavaro","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"8851736","DOI":"10.1155\/2021\/8851736","article-title":"Pulmonary Artery Filling Defects in COVID-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication?","volume":"2021","author":"Scardapane","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"ref_169","first-page":"786","article-title":"Vaccine Adverse Events: Separating Myth from Reality","volume":"95","author":"Spencer","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 Vaccines in Development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"ref_171","unstructured":"U.S. Food and Drug Administration (2022, July 12). FDA Approves First COVID-19 Vaccine, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-covid-19-vaccine."},{"key":"ref_172","unstructured":"(2022, July 12). EMA First COVID-19 Vaccine Approved for Children Aged 12 to 15 in EU. Available online: https:\/\/www.ema.europa.eu\/en\/news\/first-covid-19-vaccine-approved-children-aged-12-15-eu."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral Targets for Vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Gobbi, F., Buonfrate, D., Moro, L., Rodari, P., Piubelli, C., Caldrer, S., Riccetti, S., Sinigaglia, A., and Barzon, L. (2021). Antibody Response to the BNT162b2 MRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection. Viruses, 13.","DOI":"10.3390\/v13030422"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/infdis\/jiab262","article-title":"BNT162b2 MRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report","volume":"224","author":"Bianchi","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","article-title":"The Contribution of Vaccination to Global Health: Past, Present and Future","volume":"369","author":"Greenwood","year":"2014","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJMp2005630","article-title":"Developing COVID-19 Vaccines at Pandemic Speed","volume":"382","author":"Lurie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.12.011","article-title":"COVID-19 Vaccines: The Status and Perspectives in Delivery Points of View","volume":"170","author":"Chung","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.addr.2021.01.014","article-title":"SARS-CoV-2 Vaccines in Advanced Clinical Trials: Where Do We Stand?","volume":"172","author":"Chakraborty","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2020.15543","article-title":"Effect of an Inactivated Vaccine against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials","volume":"324","author":"Xia","year":"2020","journal-title":"JAMA"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an Inactivated Vaccine Candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1186\/s13063-020-04775-4","article-title":"Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of Treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac\u2014PROFISCOV: A Structured Summary of a Study Protocol for a Randomised Controlled Trial","volume":"21","author":"Palacios","year":"2020","journal-title":"Trials"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Mallapaty, S. (2021). China COVID Vaccine Reports Mixed Results\u2014What Does That Mean for the Pandemic?. Nature, 15.","DOI":"10.1038\/d41586-021-00094-z"},{"key":"ref_185","unstructured":"Prevention, B.V. (2020). A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26. COV2. S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adults Aged 18 Years and Older, in press."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/idr13020041","article-title":"COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation","volume":"13","author":"Sheikh","year":"2021","journal-title":"Infect. Dis. Rep."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and Efficacy of an RAd26 and RAd5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine: An Interim Analysis of a Randomised Controlled Phase 3 Trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.abe1502","article-title":"Structural Analysis of Full-Length SARS-CoV-2 Spike Protein from an Advanced Vaccine Candidate","volume":"370","author":"Bangaru","year":"2020","journal-title":"Science"},{"key":"ref_189","unstructured":"(2022, July 12). BioNTech SE A PHASE 1\/2\/3, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of SARS-CoV-2 RNA Vaccine Candidates against COVID-19 in Healthy Indi-viduals, Available online: clinicaltrials.gov."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Mahase, E. (2020). COVID-19: Moderna Vaccine Is Nearly 95% Effective, Trial Involving High Risk and Elderly People Shows. BMJ Br. Med. J. (Online), 371.","DOI":"10.1136\/bmj.m4471"},{"key":"ref_191","first-page":"m4670","article-title":"COVID-19: UK Government Asks Regulator to Assess Oxford Vaccine as Questions Are Raised over Interim Data","volume":"371","author":"Mahase","year":"2020","journal-title":"BMJ Br. Med. J. (Online)"},{"key":"ref_192","unstructured":"(2022, July 12). EMA EMA and ECDC Update on COVID-19. Available online: https:\/\/www.ema.europa.eu\/en\/news\/ema-ecdc-update-covid-19."},{"key":"ref_193","unstructured":"(2022, July 12). National Cohort Study of Effectiveness and Safety of SARS-CoV-2\/COVID-19 Vaccines, Available online: clinicaltrials.gov."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2100420","DOI":"10.2807\/1560-7917.ES.2021.26.17.2100420","article-title":"Effectiveness of the Comirnaty (BNT162b2, BioNTech\/Pfizer) Vaccine in Preventing SARS-CoV-2 Infection among Healthcare Workers, Treviso Province, Veneto Region, Italy, 27 December 2020 to 24 March 2021","volume":"26","author":"Fabiani","year":"2021","journal-title":"Eurosurveillance"},{"key":"ref_195","unstructured":"(2022, July 12). BioNTech\/Pfizer Vaccine Authorised Answers to Frequently Asked Questions on AIFA\u2019s Website, Available online: https:\/\/www.aifa.gov.it\/en\/-\/autorizzato-il-vaccino-biontech-pfizer."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2020.16866","article-title":"COVID-19 and MRNA Vaccines\u2014First Large Test for a New Approach","volume":"324","author":"Abbasi","year":"2020","journal-title":"JAMA"},{"key":"ref_197","unstructured":"(2022, July 12). Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/epar\/comirnaty."},{"key":"ref_198","unstructured":"(2022, July 12). Development of Therapeutics and Vaccines. Available online: https:\/\/www.eu-patient.eu\/COVID-19\/covid-resource-point\/therapeutics-and-vaccines\/."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid Nanoparticles for MRNA Delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 MRNA COVID-19 Vaccine: First Approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2107456","article-title":"Safety, Immunogenicity, and Efficacy of the BNT162b2 COVID-19 Vaccine in Adolescents","volume":"385","author":"Frenck","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L.M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., and Baum, A. (2020). BNT162b2 Induces SARS-CoV-2-Neutralising Antibodies and T Cells in Humans; Infectious Diseases (except HIV\/AIDS). medRxiv.","DOI":"10.1038\/s41586-021-03653-6"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 MRNA COVID-19 Vaccine in a Nationwide Mass Vaccination Setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"495","DOI":"10.15585\/mmwr.mm7013e3","article-title":"Interim Estimates of Vaccine Effectiveness of BNT162b2 and MRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers\u2014Eight U.S. Locations, December 2020\u2013March 2021","volume":"70","author":"Thompson","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Patano, A., Cirulli, N., Beretta, M., Plantamura, P., Inchingolo, A.D., Inchingolo, A.M., Bordea, I.R., Malcangi, G., Marinelli, G., and Scarano, A. (2021). Education Technology in Orthodontics and Paediatric Dentistry during the COVID-19 Pandemic: A Systematic Review. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18116056"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Bordea, I.R., Xhajanka, E., Candrea, S., Bran, S., Oni\u0219or, F., Inchingolo, A.D., Malcangi, G., Pham, V.H., Inchingolo, A.M., and Scarano, A. (2020). Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners. Microorganisms, 8.","DOI":"10.3390\/microorganisms8111704"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"m3249","DOI":"10.1136\/bmj.m3249","article-title":"Clinical Characteristics of Children and Young People Admitted to Hospital with COVID-19 in United Kingdom: Prospective Multicentre Observational Cohort Study","volume":"370","author":"Swann","year":"2020","journal-title":"BMJ"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tripleo.2010.05.059","article-title":"Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in Human Cell Cultures: Growth Factor Release and Contradictory Results","volume":"110","author":"Inchingolo","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/archdischild-2021-322655","article-title":"Initial Experience of the Safety and Tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) Vaccine in Extremely Vulnerable Children Aged 12\u201315 Years","volume":"107","author":"King","year":"2022","journal-title":"Arch. Dis. Child."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Callaway, E. (2020). What Pfizer\u2019s Landmark COVID Vaccine Results Mean for the Pandemic. Nature.","DOI":"10.1038\/d41586-020-03166-8"},{"key":"ref_211","unstructured":"WHO (2021). Vaccine Tracker and Landscape, WHO."},{"key":"ref_212","unstructured":"(2021, January 04). Draft Landscape of COVID-19 Candidate Vaccines. Available online: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II Study of COVID-19 RNA Vaccine BNT162b1 in Adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"key":"ref_214","unstructured":"Pfizer, U.S. (2021, January 04). CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and Biontech COVID-19 Vaccine for Persons Ages 16 Years and Older 2020. Available online: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/us-cdc-committee-independent-health-experts-recommends."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMc2102017","article-title":"Neutralizing Activity of BNT162b2-Elicited Serum","volume":"384","author":"Liu","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 MRNA COVID-19 Vaccine in a Nationwide Setting","volume":"385","author":"Barda","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.15585\/mmwr.mm695152e1","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\u2014United States, December 2020","volume":"69","author":"Oliver","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_218","unstructured":"(2022, July 12). COVID-19 Vaccine Tracker and Landscape. Available online: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.31751","article-title":"American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease","volume":"74","author":"Fix","year":"2021","journal-title":"Hepatology"},{"key":"ref_220","unstructured":"(2021, January 04). COVID-19, Il Vaccino Astra Zeneca Efficace \u201cper Errore\u201d Univadis. Available online: https:\/\/www.univadis.it\/viewarticle\/covid-19-il-vaccino-astra-zeneca-efficace-per-errore-734126."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(21)00628-0","article-title":"Efficacy of ChAdOx1 NCoV-19 (AZD1222) Vaccine against SARS-CoV-2 Variant of Concern 202012\/01 (B.1.1.7): An Exploratory Analysis of a Randomised Controlled Trial","volume":"397","author":"Emary","year":"2021","journal-title":"Lancet"},{"key":"ref_222","unstructured":"PINHO, A.C. (2021, March 12). COVID-19 Vaccine AstraZeneca: PRAC Preliminary View Suggests No Specific Issue with Batch Used in Austria. Available online: https:\/\/www.ema.europa.eu\/en\/news\/covid-19-vaccine-astrazeneca-prac-preliminary-view-suggests-no-specific-issue-batch-used-austria."},{"key":"ref_223","unstructured":"(2022, July 12). AIFA Imposes Ban of Use of AstraZeneca Batch. Investigations in Progress in Coordination with EMA, Available online: https:\/\/www.aifa.gov.it\/en\/web\/guest\/-\/aifa-dispone-divieto-di-utilizzo-di-un-lotto-astrazeneca-accertamenti-in-corso-in-coordinamento-con-ema."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbiotec.2019.12.016","article-title":"Hydroxytyrosol: A Natural Compound with Promising Pharmacological Activities","volume":"309","author":"Bertelli","year":"2020","journal-title":"J. Biotechnol."},{"key":"ref_225","first-page":"e2020022","article-title":"A Pilot Study on the Preventative Potential of Alpha-Cyclodextrin and Hydroxytyrosol against SARS-CoV-2 Transmission","volume":"91","author":"Ergoren","year":"2020","journal-title":"Acta Bio Med. Atenei Parm."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2020-12-2","article-title":"The Race to a COVID-19 Vaccine: Opportunities and Challenges in Development and Distribution","volume":"10","author":"Burgos","year":"2021","journal-title":"DIC"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"eabe0948","DOI":"10.1126\/scitranslmed.abe0948","article-title":"Prospects for a Safe COVID-19 Vaccine","volume":"12","author":"Haynes","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_228","unstructured":"Commissioner, O. (2021, March 11). of the FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-issues-emergency-use-authorization-third-covid-19-vaccine."},{"key":"ref_229","unstructured":"(2021, March 02). Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine|National Institutes of Health (NIH), Available online: https:\/\/www.nih.gov\/news-events\/news-releases\/statement-nih-barda-fda-emergency-use-authorization-janssen-covid-19-vaccine."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Ashraf, M.U., Kim, Y., Kumar, S., Seo, D., Ashraf, M., and Bae, Y.-S. (2021). COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines, 9.","DOI":"10.3390\/vaccines9020171"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/gutjnl-2020-320953","article-title":"Digestive System Is a Potential Route of COVID-19: An Analysis of Single-Cell Coexpression Pattern of Key Proteins in Viral Entry Process","volume":"69","author":"Zhang","year":"2020","journal-title":"Gut"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"15511","DOI":"10.1128\/JVI.79.24.15511-15524.2005","article-title":"Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the Lungs","volume":"79","author":"Sims","year":"2005","journal-title":"J. Virol."},{"key":"ref_234","unstructured":"(2022, July 12). Biopharma-Reporter.Com Vaxart\u2019s Oral COVID-19 Tablet V\u2014Cerca Con Google. Available online: https:\/\/www.google.it\/search?q=biopharma-reporter.com+Vaxart%E2%80%99s+Oral+COVID-19+Tablet+V&ei=ribNYuvfOK2-xc8PsdSioAo&ved=0ahUKEwjr7orc7fL4AhUtX_EDHTGqCKQQ4dUDCA4&uact=5&oq=biopharma-reporter.com+Vaxart%E2%80%99s+Oral+COVID-19+Tablet+V&gs_lcp=Cgdnd3Mtd2l6EAMyBAghEBVKBAhBGAFKBAhGGABQzgdYzgdglgtoAXAAeACAAbcCiAG3ApIBAzMtMZgBAKABAqABAcABAQ&sclient=gws-wiz."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate Immunity to Influenza Virus Infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_236","unstructured":"(2022, July 12). iosBio Stabilitech Biopharma Announces Name Change to IosBio. Available online: https:\/\/www.globenewswire.com\/news-release\/2020\/09\/30\/2101099\/0\/en\/Stabilitech-Biopharma-announces-name-change-to-iosBio.html."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/d41586-021-01061-4","article-title":"COVID Vaccines and Kids: Five Questions as Trials Begin","volume":"592","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"ref_238","first-page":"365","article-title":"Compliance of Children with Removable Functional Appliance with Microchip Integrated during COVID-19 Pandemic: A Systematic Review","volume":"35","author":"Montenegro","year":"2021","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_239","unstructured":"Rose, A., Stevo, C., Alatovic, J., and Maas, S. (2021). Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years, Pfizer Inc."},{"key":"ref_240","unstructured":"(The Guardian, 2021). 240. Reuters CDC Backs Pfizer COVID-19 Vaccine for Young Children, The Guardian."},{"key":"ref_241","unstructured":"(2022, January 07). CDC COVID-19 Vaccines for Children & Teens, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/children-teens.html."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiaa666","article-title":"Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient","volume":"223","author":"Baang","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/uog.23619","article-title":"Pregnancy and Neonatal Outcomes of COVID-19: Coreporting of Common Outcomes from PAN-COVID and AAP-SONPM Registries","volume":"57","author":"Mullins","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0140-6736(21)00716-9","article-title":"Were Pregnant Women More Affected by COVID-19 in the Second Wave of the Pandemic?","volume":"397","author":"Kadiwar","year":"2021","journal-title":"Lancet"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Malcangi, G., Inchingolo, A.D., Inchingolo, A.M., Santacroce, L., Marinelli, G., Mancini, A., Vimercati, L., Maggiore, M.E., D\u2019Oria, M.T., and Hazballa, D. (2021). COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies. Microorganisms, 9.","DOI":"10.3390\/microorganisms9091964"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/M21-0173","article-title":"Inclusion of Pregnant and Lactating Persons in COVID-19 Vaccination Efforts","volume":"174","author":"Riley","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_247","first-page":"6901131","article-title":"BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age","volume":"2021","author":"Mangat","year":"2021","journal-title":"Case Rep. Pediatr."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-0041-1726390","article-title":"COVID-19 Vaccine Considerations during Pregnancy and Lactation","volume":"38","author":"Blumberg","year":"2021","journal-title":"Am. J. Perinatol."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Pace, R.M., Williams, J.E., J\u00e4rvinen, K.M., Belfort, M.B., Pace, C.D., Lackey, K.A., Gogel, A.C., Nguyen-Contant, P., Kanagaiah, P., and Fitzgerald, T. (2020). COVID-19 and Human Milk: SARS-CoV-2, Antibodies, and Neutralizing Capacity. medRxiv.","DOI":"10.1101\/2020.09.16.20196071"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00210-020-01911-4","article-title":"Vitamin D Can Prevent COVID-19 Infection-Induced Multiple Organ Damage","volume":"393","author":"Aygun","year":"2020","journal-title":"Naunyn Schmiedebergs Arch. Pharm."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/cid\/cit289","article-title":"Low Serum 25-Hydroxyvitamin D Level and Risk of Upper Respiratory Tract Infection in Children and Adolescents","volume":"57","author":"Science","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Gunasekar, P., Swier, V.J., Fleegel, J.P., Boosani, C.S., Radwan, M.M., and Agrawal, D.K. (2018). Vitamin D and Macrophage Polarization in Epicardial Adipose Tissue of Atherosclerotic Swine. PLoS ONE, 13.","DOI":"10.1101\/342493"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.12998\/wjcc.v8.i18.3920","article-title":"Special Features of SARS-CoV-2 in Daily Practice","volume":"8","author":"Charitos","year":"2020","journal-title":"WJCC"},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Vimercati, L., De Maria, L., Quarato, M., Caputi, A., Gesualdo, L., Migliore, G., Cavone, D., Sponselli, S., Pipoli, A., and Inchingolo, F. (2021). Association between Long COVID and Overweight\/Obesity. JCM, 10.","DOI":"10.3390\/jcm10184143"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Santacroce, L., Charitos, I.A., Ballini, A., Inchingolo, F., Luperto, P., De Nitto, E., and Topi, S. (2020). The Human Respiratory System and Its Microbiome at a Glimpse. Biology, 9.","DOI":"10.3390\/biology9100318"},{"key":"ref_256","first-page":"616","article-title":"MRNA Vaccine-Elicited Antibodies to SARS-CoV-2 and Circulating Variants","volume":"592","author":"Wang","year":"2021","journal-title":"Immunology"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.2021.7563","article-title":"Immunogenicity of COVID-19 MRNA Vaccines in Pregnant and Lactating Women","volume":"325","author":"McMahan","year":"2021","journal-title":"JAMA"},{"key":"ref_258","first-page":"1848","article-title":"Antibodies in Infants Born to Mothers With COVID-19 Pneumonia","volume":"323","author":"Zeng","year":"2020","journal-title":"JAMA"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/2101070a0","article-title":"Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport","volume":"210","author":"Kohler","year":"1966","journal-title":"Nature"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/00313020600696280","article-title":"The Placentas of Patients with Severe Acute Respiratory Syndrome: A Pathophysiological Evaluation","volume":"38","author":"Ng","year":"2006","journal-title":"Pathology"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/jama.2021.5782","article-title":"SARS-CoV-2\u2013Specific Antibodies in Breast Milk after COVID-19 Vaccination of Breastfeeding Women","volume":"325","author":"Perl","year":"2021","journal-title":"JAMA"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/jgs.17136","article-title":"Lessons Learned from Frontline Skilled Nursing Facility Staff Regarding COVID-19 Vaccine Hesitancy","volume":"69","author":"Berry","year":"2021","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/jama.2021.9976","article-title":"Sperm Parameters Before and After COVID-19 MRNA Vaccination","volume":"326","author":"Gonzalez","year":"2021","journal-title":"JAMA"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.jiph.2021.08.006","article-title":"Palms and Soles Itchiness as a Side Effect of COVID-19 Vaccination","volume":"14","year":"2021","journal-title":"J. Infect Public Health"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.121.055913","article-title":"Myocarditis After BNT162b2 and MRNA-1273 Vaccination","volume":"144","author":"Larson","year":"2021","journal-title":"Circulation"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis With COVID-19 MRNA Vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"e2021052478","DOI":"10.1542\/peds.2021-052478","article-title":"Symptomatic Acute Myocarditis in 7 Adolescents after Pfizer-BioNTech COVID-19 Vaccination","volume":"148","author":"Marshall","year":"2021","journal-title":"Pediatrics"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ane.13417","article-title":"The Potential Neurological Effect of the COVID-19 Vaccines: A Review","volume":"144","author":"Lu","year":"2021","journal-title":"Acta Neurol. Scand."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2021.04.002","article-title":"Low Rates of Urologic Side Effects Following Coronavirus Disease Vaccination: An Analysis of the Food and Drug Administration Vaccine Adverse Event Reporting System","volume":"153","author":"Zhao","year":"2021","journal-title":"Urology"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1111\/jocd.14268","article-title":"Herpes Zoster after Inactivated COVID-19 Vaccine: A Cutaneous Adverse Effect of the Vaccine","volume":"20","author":"Arora","year":"2021","journal-title":"J Cosmet Dermtol."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jcu.23056","article-title":"Breast Implant Seroma: A SARS-CoV-2 MRNA Vaccine Side Effect","volume":"49","author":"Kayser","year":"2021","journal-title":"J. Clin. Ultrasound."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/14760584.2021.1940145","article-title":"Reported Adverse Effects Following COVID-19 Vaccination at a Tertiary Care Hospital, Focus on Cerebral Venous Sinus Thrombosis (CVST)","volume":"20","author":"Esba","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.ajkd.2021.03.010","article-title":"Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine","volume":"78","author":"Lebedev","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"101136","DOI":"10.1016\/j.ajoc.2021.101136","article-title":"Acute-Onset Central Serous Retinopathy after Immunization with COVID-19 MRNA Vaccine","volume":"23","author":"Fowler","year":"2021","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1002\/mus.27255","article-title":"Parsonage Turner Syndrome after COVID-19 Vaccination","volume":"64","author":"Mahajan","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jop.13165","article-title":"Reported Orofacial Adverse Effects of COVID-19 Vaccines: The Knowns and the Unknowns","volume":"50","author":"Cirillo","year":"2021","journal-title":"J. Oral Pathol. Med."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/ajt.16615","article-title":"Reduced Humoral Response to MRNA SARS-CoV-2 BNT162b2 Vaccine in Kidney Transplant Recipients without Prior Exposure to the Virus","volume":"21","author":"Grupper","year":"2021","journal-title":"Am. J. Transpl."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/cid\/ciab580","article-title":"Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients","volume":"74","author":"Mazzola","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.15585\/mmwr.mm7031e1","article-title":"COVID-19 Vaccine Safety in Adolescents Aged 12\u201317 Years\u2014United States, December 14, 2020\u2013July 16, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/S2665-9913(21)00218-6","article-title":"Adult-Onset Still\u2019s Disease Following COVID-19 Vaccination","volume":"3","author":"Leone","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"102688","DOI":"10.1016\/j.jaut.2021.102688","article-title":"Auto-Immune Hepatitis Following COVID Vaccination","volume":"123","author":"Rela","year":"2021","journal-title":"J. Autoimmun."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/liv.13458","article-title":"The International Autoimmune Hepatitis Group (IAIHG) Autoimmune Hepatitis: From Current Knowledge and Clinical Practice to Future Research Agenda","volume":"38","author":"Sebode","year":"2018","journal-title":"Liver Int."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"e01226","DOI":"10.1016\/j.idcr.2021.e01226","article-title":"Guillain-Barre Syndrome 15 Days after COVID-19 despite SARS-CoV-2 Vaccination","volume":"25","author":"Finsterer","year":"2021","journal-title":"IDCases"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/jth.15346","article-title":"Successful Treatment of Vaccine-induced Prothrombotic Immune Thrombocytopenia (VIPIT)","volume":"19","author":"Thaler","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"708665","DOI":"10.3389\/fphar.2021.708665","article-title":"Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis","volume":"12","author":"Cox","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_286","doi-asserted-by":"crossref","unstructured":"Cocco, G., Delli Pizzi, A., Fabiani, S., Cocco, N., Boccatonda, A., Frisone, A., Scarano, A., and Schiavone, C. (2021). Lymphadenopathy after the Anti-COVID-19 Vaccine: Multiparametric Ultrasound Findings. Biology, 10.","DOI":"10.3390\/biology10070652"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13244-021-01062-x","article-title":"Axillary Lymphadenopathy at the Time of COVID-19 Vaccination: Ten Recommendations from the European Society of Breast Imaging (EUSOBI)","volume":"12","author":"Schiaffino","year":"2021","journal-title":"Insights Imaging"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"102663","DOI":"10.1016\/j.jaut.2021.102663","article-title":"Perspectives on Vaccine Induced Thrombotic Thrombocytopenia","volume":"121","author":"Dotan","year":"2021","journal-title":"J. Autoimmun."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0029-1233537","article-title":"Vaccination as a Triggering Event for Autoimmune Hepatitis","volume":"29","author":"Perumalswami","year":"2009","journal-title":"Semin. Liver Dis."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/00365521.2016.1224379","article-title":"Vaccine-Related Autoimmune Hepatitis: The Same Disease as Idiopathic Autoimmune Hepatitis? Two Clinical Reports and Review","volume":"52","author":"Doukas","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"103078","DOI":"10.1016\/j.isci.2021.103078","article-title":"Development of Humoral and Cellular Immunological Memory against SARS-CoV-2 despite B Cell Depleting Treatment in Multiple Sclerosis","volume":"24","author":"Ruffin","year":"2021","journal-title":"iScience"},{"key":"ref_292","first-page":"227","article-title":"White Spot Lesions in Orthodontics: Prevention and Treatment. A Descriptive Review","volume":"35","author":"Marinelli","year":"2021","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_293","unstructured":"Adina, S. (2020). Orthopedic Joint Stability Influences Growth and Maxillary Development: Clinical Aspects. J. Biol. Regul. Homeost. Agents, 34."},{"key":"ref_294","first-page":"59","article-title":"Comparison of Conventional Orthognathic Surgery and \u201cSurgery-First\u201d Protocol: A New Weapon against Time","volume":"33","author":"Patianna","year":"2019","journal-title":"J. Biol. Regul. Homeost Agents"},{"key":"ref_295","first-page":"901","article-title":"Characterization of Human Apical Papilla-Derived Stem Cells","volume":"31","author":"Cantore","year":"2017","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_296","first-page":"263","article-title":"Combined Sea Salt-Based Oral Rinse with Xylitol in Orthodontic Patients: Clinical and Microbiological Study","volume":"33","author":"Ballini","year":"2019","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/0394632015590949","article-title":"Evaluation of an Oral Appliance in Patients with Mild to Moderate Obstructive Sleep Apnea Syndrome Intolerant to Continuous Positive Airway Pressure Use: Preliminary Results","volume":"29","author":"Cantore","year":"2016","journal-title":"Int. J. Immunopathol. Pharm."},{"key":"ref_298","first-page":"1626","article-title":"A Comparative Study on Different Stemness Gene Expression between Dental Pulp Stem Cells vs. Dental Bud Stem Cells","volume":"23","author":"Ballini","year":"2019","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"102442","DOI":"10.1016\/j.msard.2020.102442","article-title":"Mild Clinical Manifestations of SARS-CoV-2 Related Pneumonia in Two Patients with Multiple Sclerosis under Treatment with Ocrelizumab","volume":"45","author":"Iannetta","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1007\/s00415-021-10463-3","article-title":"Negative Anti-SARS-CoV-2 S Antibody Response Following Pfizer SARS-CoV-2 Vaccination in a Patient on Ocrelizumab","volume":"268","author":"Conway","year":"2021","journal-title":"J. Neurol."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"102851","DOI":"10.1016\/j.msard.2021.102851","article-title":"Blunted Vaccines Responses after Ocrelizumab Highlight Need for Immunizations Prior to Treatment","volume":"50","author":"Smets","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"102341","DOI":"10.1016\/j.msard.2020.102341","article-title":"Negative SARS-CoV-2 Antibody Testing Following COVID-19 Infection in Two MS Patients Treated with Ocrelizumab","volume":"44","author":"Thornton","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_303","first-page":"17562864211012836","article-title":"Humoral Immune Response to COVID-19 MRNA Vaccine in Patients with Multiple Sclerosis Treated with High-Efficacy Disease-Modifying Therapies","volume":"14","author":"Achiron","year":"2021","journal-title":"Adv. Neurol. Disord."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"e3130","DOI":"10.1093\/cid\/ciaa1537","article-title":"Interferon-\u03b3 Release Assay for Accurate Detection of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Response","volume":"73","author":"Murugesan","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"103157","DOI":"10.1016\/j.msard.2021.103157","article-title":"T-Cell Responses to SARS-CoV-2 in Multiple Sclerosis Patients Treated with Ocrelizumab Healed from COVID-19 with Absent or Low Anti-Spike Antibody Titers","volume":"55","author":"Iannetta","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"571416","DOI":"10.3389\/fphys.2020.571416","article-title":"Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?","volume":"11","author":"Bajaj","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41564-021-00947-3","article-title":"Antibody Responses to SARS-CoV-2 Vaccines in 45,965 Adults from the General Population of the United Kingdom","volume":"6","author":"Wei","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"e214302","DOI":"10.1001\/jamanetworkopen.2021.4302","article-title":"Association of Age With SARS-CoV-2 Antibody Response","volume":"4","author":"Yang","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.orcp.2018.07.001","article-title":"Frequency of Regulatory B Cells in Adipose Tissue and Peripheral Blood from Individuals with Overweight, Obesity and Normal-Weight","volume":"12","year":"2018","journal-title":"Obes. Res. Clin. Pract."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/ijo.2011.208","article-title":"Obesity Is Associated with Impaired Immune Response to Influenza Vaccination in Humans","volume":"36","author":"Sheridan","year":"2012","journal-title":"Int. J. Obes."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/08916930600597326","article-title":"Reduced Tetanus Antibody Titers in Overweight Children","volume":"39","author":"Eliakim","year":"2006","journal-title":"Autoimmunity"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1681\/ASN.2021040432","article-title":"Immunogenicity of SARS-CoV-2 Vaccine in Dialysis","volume":"32","author":"Lacson","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41408-021-00534-z","article-title":"Weak Immunogenicity of SARS-CoV-2 Vaccine in Patients with Hematologic Malignancies","volume":"11","author":"Malard","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., and Kohli, E. (2021). Impact of Low-Dose Methotrexate\u2013Adalimumab Combination Therapy on the Antibody Response Induced by the MRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis. Vaccines, 9.","DOI":"10.3390\/vaccines9080883"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"100290","DOI":"10.1016\/j.xcrm.2021.100290","article-title":"Longitudinal Analysis of Humoral Immunity against SARS-CoV-2 Spike in Convalescent Individuals up to 8 Months Post-Symptom Onset","volume":"2","author":"Anand","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.vaccine.2021.07.047","article-title":"Patients with History of COVID-19 Had More Side Effects after the First Dose of COVID-19 Vaccine","volume":"39","author":"Tissot","year":"2021","journal-title":"Vaccine"},{"key":"ref_317","doi-asserted-by":"crossref","unstructured":"Modenese, A., Paduano, S., Bargellini, A., Bellucci, R., Marchetti, S., Bruno, F., Grazioli, P., Vivoli, R., and Gobba, F. (2021). Neutralizing Anti-SARS-CoV-2 Antibody Titer and Reported Adverse Effects, in a Sample of Italian Nursing Home Personnel after Two Doses of the BNT162b2 Vaccine Administered Four Weeks Apart. Vaccines, 9.","DOI":"10.3390\/vaccines9060652"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"e01687-18","DOI":"10.1128\/JVI.01687-18","article-title":"Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques","volume":"93","author":"Musich","year":"2019","journal-title":"J. Virol."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 MRNA Vaccines Induce Persistent Human Germinal Centre Responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","article-title":"Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19","volume":"183","author":"Kaneko","year":"2020","journal-title":"Cell"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41591-020-01179-4","article-title":"Phase 1\/2 Trial of SARS-CoV-2 Vaccine ChAdOx1 NCoV-19 with a Booster Dose Induces Multifunctional Antibody Responses","volume":"27","author":"Barrett","year":"2021","journal-title":"Nat. Med."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing Antibody Levels Are Highly Predictive of Immune Protection from Symptomatic SARS-CoV-2 Infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"584251","DOI":"10.3389\/fmicb.2020.584251","article-title":"Anti-Spike, Anti-Nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals","volume":"11","author":"Brochot","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_324","doi-asserted-by":"crossref","unstructured":"Tauzin, A., Nayrac, M., Benlarbi, M., Gong, S.Y., Gasser, R., Beaudoin-Bussi\u00e8res, G., Brassard, N., Laumaea, A., V\u00e9zina, D., and Pr\u00e9vost, J. (2021). A Single BNT162b2 MRNA Dose Elicits Antibodies with Fc-Mediated Effector Functions and Boost Pre-Existing Humoral and T Cell Responses. Immunology, preprint.","DOI":"10.1101\/2021.03.18.435972"},{"key":"ref_325","doi-asserted-by":"crossref","unstructured":"Trougakos, I.P., Terpos, E., Zirou, C., Sklirou, A.D., Apostolakou, F., Gumeni, S., Charitaki, I., Papanagnou, E.-D., Bagratuni, T., and Liacos, C.-I. (2021). Comparative Kinetics of SARS-CoV-2 Anti-Spike Protein RBD IgGs and Neutralizing Antibodies in Convalescent and Na\u00efve Recipients of the BNT162b2 MRNA Vaccine versus COVID-19 Patients. BMC Med., 19.","DOI":"10.1186\/s12916-021-02090-6"},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"e149154","DOI":"10.1172\/JCI149154","article-title":"One Dose of SARS-CoV-2 Vaccine Exponentially Increases Antibodies in Individuals Who Have Recovered from Symptomatic COVID-19","volume":"131","author":"Levi","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1056\/NEJMc2103916","article-title":"Antibody Persistence through 6 Months after the Second Dose of MRNA-1273 Vaccine for COVID-19","volume":"384","author":"Suthar","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_328","doi-asserted-by":"crossref","unstructured":"Scarano, A., Noumbissi, S., Gupta, S., Inchingolo, F., Stilla, P., and Lorusso, F. (2019). Scanning Electron Microscopy Analysis and Energy Dispersion X-Ray Microanalysis to Evaluate the Effects of Decontamination Chemicals and Heat Sterilization on Implant Surgical Drills: Zirconia vs. Steel. Appl. Sci., 9.","DOI":"10.3390\/app9142837"},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Scarano, A., Piattelli, A., Assenza, B., Carinci, F., Donato, L.D., and Romani GLMerla, A. (2020). Infrared Thermographic Evaluation of Temperature Modifications Induced during Implant Site Preparation with Steel vs. Zirconia Implant Drill. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010148"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"190","DOI":"10.11138\/orl\/2017.10.2.190","article-title":"Delayed Expansion of Atrophic Mandible (Deam): A Case Report","volume":"10","author":"Scarano","year":"2017","journal-title":"Oral Implantol."},{"key":"ref_331","doi-asserted-by":"crossref","unstructured":"Balzanelli, M.G., Distratis, P., Dipalma, G., Vimercati, L., Inchingolo, A.D., Lazzaro, R., Aityan, S.K., Maggiore, M.E., Mancini, A., and Laforgia, R. (2021). SARS-CoV-2 Virus Infection May Interfere CD34+ Hematopoietic Stem Cells and Megakaryocyte\u2013Erythroid Progenitors Differentiation Contributing to Platelet Defection towards Insurgence of Thrombocytopenia and Thrombophilia. Microorganisms, 9.","DOI":"10.3390\/microorganisms9081632"},{"key":"ref_332","doi-asserted-by":"crossref","unstructured":"Rapone, B., Ferrara, E., Corsalini, M., Qorri, E., Converti, I., Lorusso, F., Delvecchio, M., Gnoni, A., Scacco, S., and Scarano, A. (2021). Inflammatory Status and Glycemic Control Level of Patients with Type 2 Diabetes and Periodontitis: A Randomized Clinical Trial. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18063018"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"745","DOI":"10.11607\/prd.2719","article-title":"Bone Response to Four Dental Implants with Different Surface Topographies: A Histologic and Histometric Study in Minipigs","volume":"36","author":"Kalemaj","year":"2016","journal-title":"Int. J. Periodontics Restor. Dent."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/clr.13528","article-title":"Dimensional Changes of Buccal Bone Plate in Immediate Implants Inserted through Open Flap, Open Flap and Bone Grafting and Flapless Techniques: A Cone-Beam Computed Tomography Randomized Controlled Clinical Trial","volume":"30","author":"Grassi","year":"2019","journal-title":"Clin. Oral Implants Res."},{"key":"ref_335","doi-asserted-by":"crossref","unstructured":"Lorusso, F., Noumbissi, S., Francesco, I., Rapone, B., Khater, A.G.A., and Scarano, A. (2020). Scientific Trends in Clinical Research on Zirconia Dental Implants: A Bibliometric Review. Materials, 13.","DOI":"10.3390\/ma13235534"},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/22221751.2021.1953403","article-title":"Antibody Titres Decline 3-Month Post-Vaccination with BNT162b2","volume":"10","author":"Favresse","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_337","doi-asserted-by":"crossref","unstructured":"Lorusso, F., Tartaglia, G., Inchingolo, F., and Scarano, A. (2022). Early Response and Clinical Efficacy of a Mouthwash Containing Chlorhexidine, Anti Discoloration System, Polyvinylpyrrolidone\/Vinyl Acetate and Sodium DNA in Periodontitis Model: A Triple-Blind Randomized Controlled Clinical Trial. Dent. J., 10.","DOI":"10.3390\/dj10060101"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/cid\/ciab381","article-title":"Age-Dependent Immune Response to the Biontech\/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination","volume":"73","author":"Moskorz","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_339","doi-asserted-by":"crossref","unstructured":"Macedo-Ojeda, G., Mu\u00f1oz-Valle, J., Yokogawa-Teraoka, P., Machado-Sulbar\u00e1n, A., Loza-Rojas, M., Arredondo, A.G., Tejeda-Constantini, R., Vega-Maga\u00f1a, A., Gonz\u00e1lez-Estevez, G., and Garc\u00eda-Chagoll\u00e1n, M. (2021). COVID-19 Screening By Anti-SARS-CoV-2 Antibody Seropositivity: Clinical And Epidemiological Characteristics, Comorbidities, And Food Intake Quality. Int. J. Environ. Res. Public Health, 18.","DOI":"10.21203\/rs.3.rs-154551\/v1"},{"key":"ref_340","doi-asserted-by":"crossref","unstructured":"Pellini, R., Venuti, A., Pimpinelli, F., Abril, E., Blandino, G., Campo, F., Conti, L., De Virgilio, A., De Marco, F., and Di Domenico, E.G. (2021). Early Onset of SARS-CoV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI. Vaccines, 9.","DOI":"10.3390\/vaccines9070685"},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"339","DOI":"10.31083\/j.rcm.2020.03.131","article-title":"Vitamin D Deficiency in Association with Endothelial Dysfunction: Implications for Patients WithCOVID-19","volume":"21","author":"Zhang","year":"2020","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_342","doi-asserted-by":"crossref","unstructured":"Bellocchio, L., Bordea, I.R., Ballini, A., Lorusso, F., Hazballa, D., Isacco, C.G., Malcangi, G., Inchingolo, A.D., Dipalma, G., and Inchingolo, F. (2020). Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17218049"},{"key":"ref_343","doi-asserted-by":"crossref","unstructured":"Inchingolo, F., Martelli, F.S., Gargiulo Isacco, C., Borsani, E., Cantore, S., Corcioli, F., Boddi, A., Nguy\u1ec5n, K.C.D., De Vito, D., and Aityan, S.K. (2020). Chronic Periodontitis and Immunity, Towards the Implementation of a Personalized Medicine: A Translational Research on Gene Single Nucleotide Polymorphisms (SNPs) Linked to Chronic Oral Dysbiosis in 96 Caucasian Patients. Biomedicines, 8.","DOI":"10.3390\/biomedicines8050115"},{"key":"ref_344","first-page":"8645","article-title":"Effect of Probiotics on the Occurrence of Nutrition Absorption Capacities in Healthy Children: A Randomized Double-Blinded Placebo-Controlled Pilot Study","volume":"23","author":"Ballini","year":"2019","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.dsx.2020.12.040","article-title":"Potential Beneficial Role of Probiotics on the Outcome of COVID-19 Patients: An Evolving Perspective","volume":"15","author":"Santacroce","year":"2021","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against Type I IFNs in Patients with Life-Threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and Distinct Functions of Type I and Type III Interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"ref_348","doi-asserted-by":"crossref","unstructured":"Balzanelli, M.G., Distratis, P., Dipalma, G., Vimercati, L., Catucci, O., Amatulli, F., Cefalo, A., Lazzaro, R., Palazzo, D., and Aityan, S.K. (2021). Immunity Profiling of COVID-19 Infection, Dynamic Variations of Lymphocyte Subsets, a Comparative Analysis on Four Different Groups. Microorganisms, 9.","DOI":"10.3390\/microorganisms9102036"},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"e01928-20","DOI":"10.1128\/mBio.01928-20","article-title":"Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2","volume":"11","author":"Busnadiego","year":"2020","journal-title":"mBio"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and Antiphospholipid Antibodies in Patients with COVID-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/cts.12805","article-title":"Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19","volume":"13","author":"Zhou","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"2100918","DOI":"10.1183\/13993003.00918-2021","article-title":"Autoimmunity to Annexin A2 Predicts Mortality among Hospitalised COVID-19 Patients","volume":"58","author":"Zuniga","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"e202101180","DOI":"10.26508\/lsa.202101180","article-title":"Autoimmune Anti-DNA and Anti-Phosphatidylserine Antibodies Predict Development of Severe COVID-19","volume":"4","author":"Gomes","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the Human Innate Immune System","volume":"184","author":"Schultze","year":"2021","journal-title":"Cell"},{"key":"ref_355","first-page":"908","article-title":"Immunit\u00e9 Adaptative Contre Le Virus SARS-CoV-2","volume":"36","year":"2020","journal-title":"Med. Sci."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"abm0829","DOI":"10.1126\/science.abm0829","article-title":"MRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0950268800048019","article-title":"The Time Course of the Immune Response to Experimental Coronavirus Infection of Man","volume":"105","author":"Callow","year":"1990","journal-title":"Epidemiol. Infect."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40246-021-00326-3","article-title":"COVID-19 One Year into the Pandemic: From Genetics and Genomics to Therapy, Vaccination, and Policy","volume":"15","author":"Novelli","year":"2021","journal-title":"Hum. Genom."},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"e2026309118","DOI":"10.1073\/pnas.2026309118","article-title":"A Genomic Region Associated with Protection against Severe COVID-19 Is Inherited from Neandertals","volume":"118","author":"Zeberg","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of Concomitant Immune Responses Prior to Patient Recovery: A Case Report of Non-Severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat. Med."},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3389\/fimmu.2020.01748","article-title":"Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response","volume":"11","author":"Cunha","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors Associated with COVID-19-Related Death Using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00134-021-06392-4","article-title":"Autoantibodies against Type I Interferons Are Associated with Multi-Organ Failure in COVID-19 Patients","volume":"47","author":"Koning","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41392-021-00514-6","article-title":"Auto-Antibodies against Type I IFNs Are Associated with Severe COVID-19 Pneumonia","volume":"6","author":"Zhou","year":"2021","journal-title":"Sig. Transduct. Target"},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-Cell Landscape of Bronchoalveolar Immune Cells in Patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"e20201707","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes Are Activated in Response to SARS-CoV-2 Infection and Are Associated with COVID-19 Severity in Patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40246-021-00356-x","article-title":"Update on Human Genetic Susceptibility to COVID-19: Susceptibility to Virus and Response","volume":"15","author":"Colona","year":"2021","journal-title":"Hum Genom."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining Trained Immunity and Its Role in Health and Disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"ref_369","doi-asserted-by":"crossref","unstructured":"Severe COVID-19 GWAS Group, Ellinghaus, D., Degenhardt, F., Bujanda, L., Buti, M., Albillos, A., Invernizzi, P., Fern\u00e1ndez, J., Prati, D., and Baselli, G. (2020). Genomewide Association Study of Severe COVID-19 with Respiratory Failure. N. Engl. J. Med., 383, 1522\u20131534.","DOI":"10.1056\/NEJMoa2020283"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41586-020-2818-3","article-title":"The Major Genetic Risk Factor for Severe COVID-19 Is Inherited from Neanderthals","volume":"587","author":"Zeberg","year":"2020","journal-title":"Nature"},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12325-022-02042-3","article-title":"A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab","volume":"39","author":"Villaescusa","year":"2022","journal-title":"Adv. Ther."},{"key":"ref_372","doi-asserted-by":"crossref","unstructured":"Sagris, M., Theofilis, P., Antonopoulos, A.S., Oikonomou, E., Tsioufis, K., and Tousoulis, D. (2022). Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020242"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8485\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:11Z","timestamp":1760140811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":372,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158485"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158485","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]}}}